9 false false false false false false false false false true false false false false false false No description of principal activity 2023-01-01 Sage Accounts Production Advanced 2021 - FRS102_2021 1 1 1 xbrli:pure xbrli:shares iso4217:GBP 13691257 2023-01-01 2023-12-31 13691257 2023-12-31 13691257 2022-12-31 13691257 2021-10-20 2022-12-31 13691257 2022-12-31 13691257 core:PlantMachinery 2023-01-01 2023-12-31 13691257 core:FurnitureFittings 2023-01-01 2023-12-31 13691257 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 13691257 bus:OrdinaryShareClass2 2023-01-01 2023-12-31 13691257 bus:Director1 2023-01-01 2023-12-31 13691257 core:WithinOneYear 2023-12-31 13691257 core:WithinOneYear 2022-12-31 13691257 core:PlantMachinery 2022-12-31 13691257 core:FurnitureFittings 2022-12-31 13691257 core:PlantMachinery 2023-12-31 13691257 core:FurnitureFittings 2023-12-31 13691257 core:ShareCapital 2023-12-31 13691257 core:ShareCapital 2022-12-31 13691257 core:SharePremium 2023-12-31 13691257 core:SharePremium 2022-12-31 13691257 core:RetainedEarningsAccumulatedLosses 2023-12-31 13691257 core:RetainedEarningsAccumulatedLosses 2022-12-31 13691257 core:BetweenOneFiveYears 2023-12-31 13691257 core:BetweenOneFiveYears 2022-12-31 13691257 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-12-31 13691257 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 13691257 core:Non-currentFinancialInstruments 2023-12-31 13691257 core:PlantMachinery 2022-12-31 13691257 core:FurnitureFittings 2022-12-31 13691257 bus:SmallEntities 2023-01-01 2023-12-31 13691257 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 13691257 bus:FullAccounts 2023-01-01 2023-12-31 13691257 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 13691257 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 13691257 bus:OrdinaryShareClass1 2023-12-31 13691257 bus:OrdinaryShareClass1 2022-12-31 13691257 bus:OrdinaryShareClass2 2023-12-31 13691257 bus:OrdinaryShareClass2 2022-12-31 13691257 bus:AllOrdinaryShares 2023-12-31 13691257 bus:AllOrdinaryShares 2022-12-31 13691257 core:ComputerEquipment 2023-01-01 2023-12-31 13691257 core:ComputerEquipment 2023-12-31 13691257 core:ComputerEquipment 2022-12-31 13691257 1 2023-01-01 2023-12-31
COMPANY REGISTRATION NUMBER: 13691257
PICTURA BIO LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
31 December 2023
PICTURA BIO LTD
FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2023
Contents
Pages
Balance sheet 1
Notes to the financial statements 2 to 7
PICTURA BIO LTD
BALANCE SHEET
31 December 2023
2023
2022
Note
£
£
Fixed assets
Tangible assets
5
39,747
54,774
Investments
6
1
------------
------------
39,748
54,774
Current assets
Debtors
7
410,758
83,640
Cash at bank and in hand
1,662,958
667,915
------------
------------
2,073,716
751,555
Creditors: amounts falling due within one year
8
( 133,827)
( 158,655)
------------
------------
Net current assets
1,939,889
592,900
------------
------------
Total assets less current liabilities
1,979,637
647,674
------------
------------
Net assets
1,979,637
647,674
------------
------------
Capital and reserves
Called up share capital
9
307
227
Share premium account
4,720,148
2,621,340
Profit and loss account
( 2,740,818)
( 1,973,893)
------------
------------
Shareholders funds
1,979,637
647,674
------------
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the profit and loss account has not been delivered.
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 13 August 2024 , and are signed on behalf of the board by:
Mr A J Batchelor
Director
Company registration number: 13691257
PICTURA BIO LTD
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 35 Westgate, Huddersfield, HD1 1PA, West Yorkshire.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
25% reducing balance
Fixtures and fittings
-
25% reducing balance
Equipment
-
33% straight line
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 9 (2022: 6 ).
5. Tangible assets
Plant and machinery
Fixtures and fittings
Equipment
Total
£
£
£
£
Cost
At 1 January 2023 and 31 December 2023
47,749
4,734
10,105
62,588
------------
------------
------------
------------
Depreciation
At 1 January 2023
5,071
780
1,963
7,814
Charge for the year
10,669
989
3,369
15,027
------------
------------
------------
------------
At 31 December 2023
15,740
1,769
5,332
22,841
------------
------------
------------
------------
Carrying amount
At 31 December 2023
32,009
2,965
4,773
39,747
------------
------------
------------
------------
At 31 December 2022
42,678
3,954
8,142
54,774
------------
------------
------------
------------
6. Investments
Shares in participating interests
£
Cost
At 1 January 2023
Additions
1
------------
At 31 December 2023
1
------------
Impairment
At 1 January 2023 and 31 December 2023
------------
Carrying amount
At 31 December 2023
1
------------
At 31 December 2022
------------
7. Debtors
2023
2022
£
£
Trade debtors
118,553
Prepayments and accrued income
81,527
35,000
Corporation tax repayable
210,678
Other debtors
48,640
------------
------------
410,758
83,640
------------
------------
8. Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
105,233
153,365
Amounts owed to group undertakings
1
Accruals and deferred income
5,195
Social security and other taxes
3,363
Other creditors
20,035
5,290
------------
------------
133,827
158,655
------------
------------
9. Called up share capital
Issued, called up and fully paid
2023
2022
No.
£
No.
£
Ordinary shares of £ 0.01 each
10,977
110
10,892
109
Ordinary A shares of £ 0.01 each
19,709
197
11,848
118
------------
------------
------------
------------
30,686
307
22,740
227
------------
------------
------------
------------
Shares issued and fully paid
2023
2022
No.
£
No.
£
Ordinary shares of £ 0.01 each
10,977
110
10,892
109
Ordinary A shares of £ 0.01 each
19,709
197
11,848
118
------------
------------
------------
------------
30,686
307
22,740
227
------------
------------
------------
------------
Shares issued and partly paid
2023
2022
No.
£
No.
£
During the period a total of 7,946 ordinary and ordinary A shares were issued fully paid for an aggregate cash contribution of £2,098,888. The rights of the different classes of share are set out in the company's Articles of Association.
10. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:
2023
2022
£
£
Not later than 1 year
147,412
71,652
Later than 1 year and not later than 5 years
11,831
11,942
------------
------------
159,243
83,594
------------
------------
11. Controlling party
There is no one controlling party of the Company
12. Going concern
The shareholders are providing adequate working capital to enable the Company to continue its activities. Accordingly, the accounts have been prepared on a going concern basis.